カテゴリー： Market Monitor Global, 世界, 医療/バイオ

半固体投与量の世界市場見通し2023年-2029年

◆英語タイトル：Semi-solid Dosage Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB2513）◆商品コード：MMG23FB2513
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：124
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の半固体投与量市場規模と予測を収録しています。・世界の半固体投与量市場：売上、2018年-2023年、2024年-2029年
・世界の半固体投与量市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の半固体投与量市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「軟膏」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

半固体投与量のグローバル主要企業は、Johnson & Johnson、Merck & Co、Bayer AG、Hisamitsu Pharmaceutical、Glenmark Pharmaceuticals、Cipla Ltd、Nestle SA、Novartis AG、GlaxoSmithKline plc、Bausch Health Companies、Allergan、Biofrontera、Crown Laboratories、Akorn、Ingenus Pharmaceuticals、Sun Pharmaceuticals、Crescita Therapeutics、Mylan N.V.、Encore Dermatology、LEO Pharma、Almirall, S.A、Aclaris Therapeutics、Taro Pharmaceutical Industries、Teligent Pharma、Perrigo Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、半固体投与量のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の半固体投与量市場：タイプ別、2018年-2023年、2024年-2029年
世界の半固体投与量市場：タイプ別市場シェア、2022年
・軟膏、ペースト、絆創膏、ジェル

世界の半固体投与量市場：用途別、2018年-2023年、2024年-2029年
世界の半固体投与量市場：用途別市場シェア、2022年
・皮膚、鼻腔、膣腔、直腸腔、その他

世界の半固体投与量市場：地域・国別、2018年-2023年、2024年-2029年
世界の半固体投与量市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における半固体投与量のグローバル売上、2018年-2023年
・主要企業における半固体投与量のグローバル売上シェア、2022年
・主要企業における半固体投与量のグローバル販売量、2018年-2023年
・主要企業における半固体投与量のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Johnson & Johnson、Merck & Co、Bayer AG、Hisamitsu Pharmaceutical、Glenmark Pharmaceuticals、Cipla Ltd、Nestle SA、Novartis AG、GlaxoSmithKline plc、Bausch Health Companies、Allergan、Biofrontera、Crown Laboratories、Akorn、Ingenus Pharmaceuticals、Sun Pharmaceuticals、Crescita Therapeutics、Mylan N.V.、Encore Dermatology、LEO Pharma、Almirall, S.A、Aclaris Therapeutics、Taro Pharmaceutical Industries、Teligent Pharma、Perrigo Pharma

*************************************************************

・調査・分析レポートの概要
半固体投与量市場の定義
市場セグメント
世界の半固体投与量市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の半固体投与量市場規模
世界の半固体投与量市場規模：2022年 VS 2029年
世界の半固体投与量市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの半固体投与量の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の半固体投与量製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：軟膏、ペースト、絆創膏、ジェル
半固体投与量のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：皮膚、鼻腔、膣腔、直腸腔、その他
半固体投与量の用途別グローバル売上・予測

・地域別市場分析
地域別半固体投与量市場規模 2022年と2029年
地域別半固体投与量売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Johnson & Johnson、Merck & Co、Bayer AG、Hisamitsu Pharmaceutical、Glenmark Pharmaceuticals、Cipla Ltd、Nestle SA、Novartis AG、GlaxoSmithKline plc、Bausch Health Companies、Allergan、Biofrontera、Crown Laboratories、Akorn、Ingenus Pharmaceuticals、Sun Pharmaceuticals、Crescita Therapeutics、Mylan N.V.、Encore Dermatology、LEO Pharma、Almirall, S.A、Aclaris Therapeutics、Taro Pharmaceutical Industries、Teligent Pharma、Perrigo Pharma
...

This report aims to provide a comprehensive presentation of the global market for Semi-solid Dosage, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Semi-solid Dosage. This report contains market size and forecasts of Semi-solid Dosage in global, including the following market information:
Global Semi-solid Dosage Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Semi-solid Dosage Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Semi-solid Dosage companies in 2022 (%)
The global Semi-solid Dosage market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Ointment Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Semi-solid Dosage include Johnson & Johnson, Merck & Co, Bayer AG, Hisamitsu Pharmaceutical, Glenmark Pharmaceuticals, Cipla Ltd, Nestle SA, Novartis AG and GlaxoSmithKline plc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Semi-solid Dosage manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Semi-solid Dosage Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Semi-solid Dosage Market Segment Percentages, by Type, 2022 (%)
Ointment
Paste
Plaster
Gel
Global Semi-solid Dosage Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Semi-solid Dosage Market Segment Percentages, by Application, 2022 (%)
Skin
Nasal Cavity
Vaginal Cavity
Rectal Cavity
Other
Global Semi-solid Dosage Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Semi-solid Dosage Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Semi-solid Dosage revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Semi-solid Dosage revenues share in global market, 2022 (%)
Key companies Semi-solid Dosage sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Semi-solid Dosage sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Merck & Co
Bayer AG
Hisamitsu Pharmaceutical
Glenmark Pharmaceuticals
Cipla Ltd
Nestle SA
Novartis AG
GlaxoSmithKline plc
Bausch Health Companies
Allergan
Biofrontera
Crown Laboratories
Akorn
Ingenus Pharmaceuticals
Sun Pharmaceuticals
Crescita Therapeutics
Mylan N.V.
Encore Dermatology
LEO Pharma
Almirall, S.A
Aclaris Therapeutics
Taro Pharmaceutical Industries
Teligent Pharma
Perrigo Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Semi-solid Dosage, market overview.
Chapter 2: Global Semi-solid Dosage market size in revenue and volume.
Chapter 3: Detailed analysis of Semi-solid Dosage manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Semi-solid Dosage in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Semi-solid Dosage capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Semi-solid Dosage Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Semi-solid Dosage Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Semi-solid Dosage Overall Market Size
2.1 Global Semi-solid Dosage Market Size: 2022 VS 2029
2.2 Global Semi-solid Dosage Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Semi-solid Dosage Sales: 2018-2029
3 Company Landscape
3.1 Top Semi-solid Dosage Players in Global Market
3.2 Top Global Semi-solid Dosage Companies Ranked by Revenue
3.3 Global Semi-solid Dosage Revenue by Companies
3.4 Global Semi-solid Dosage Sales by Companies
3.5 Global Semi-solid Dosage Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Semi-solid Dosage Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Semi-solid Dosage Product Type
3.8 Tier 1, Tier 2 and Tier 3 Semi-solid Dosage Players in Global Market
3.8.1 List of Global Tier 1 Semi-solid Dosage Companies
3.8.2 List of Global Tier 2 and Tier 3 Semi-solid Dosage Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Semi-solid Dosage Market Size Markets, 2022 & 2029
4.1.2 Ointment
4.1.3 Paste
4.1.4 Plaster
4.1.5 Gel
4.2 By Type – Global Semi-solid Dosage Revenue & Forecasts
4.2.1 By Type – Global Semi-solid Dosage Revenue, 2018-2023
4.2.2 By Type – Global Semi-solid Dosage Revenue, 2024-2029
4.2.3 By Type – Global Semi-solid Dosage Revenue Market Share, 2018-2029
4.3 By Type – Global Semi-solid Dosage Sales & Forecasts
4.3.1 By Type – Global Semi-solid Dosage Sales, 2018-2023
4.3.2 By Type – Global Semi-solid Dosage Sales, 2024-2029
4.3.3 By Type – Global Semi-solid Dosage Sales Market Share, 2018-2029
4.4 By Type – Global Semi-solid Dosage Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Semi-solid Dosage Market Size, 2022 & 2029
5.1.2 Skin
5.1.3 Nasal Cavity
5.1.4 Vaginal Cavity
5.1.5 Rectal Cavity
5.1.6 Other
5.2 By Application – Global Semi-solid Dosage Revenue & Forecasts
5.2.1 By Application – Global Semi-solid Dosage Revenue, 2018-2023
5.2.2 By Application – Global Semi-solid Dosage Revenue, 2024-2029
5.2.3 By Application – Global Semi-solid Dosage Revenue Market Share, 2018-2029
5.3 By Application – Global Semi-solid Dosage Sales & Forecasts
5.3.1 By Application – Global Semi-solid Dosage Sales, 2018-2023
5.3.2 By Application – Global Semi-solid Dosage Sales, 2024-2029
5.3.3 By Application – Global Semi-solid Dosage Sales Market Share, 2018-2029
5.4 By Application – Global Semi-solid Dosage Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Semi-solid Dosage Market Size, 2022 & 2029
6.2 By Region – Global Semi-solid Dosage Revenue & Forecasts
6.2.1 By Region – Global Semi-solid Dosage Revenue, 2018-2023
6.2.2 By Region – Global Semi-solid Dosage Revenue, 2024-2029
6.2.3 By Region – Global Semi-solid Dosage Revenue Market Share, 2018-2029
6.3 By Region – Global Semi-solid Dosage Sales & Forecasts
6.3.1 By Region – Global Semi-solid Dosage Sales, 2018-2023
6.3.2 By Region – Global Semi-solid Dosage Sales, 2024-2029
6.3.3 By Region – Global Semi-solid Dosage Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Semi-solid Dosage Revenue, 2018-2029
6.4.2 By Country – North America Semi-solid Dosage Sales, 2018-2029
6.4.3 US Semi-solid Dosage Market Size, 2018-2029
6.4.4 Canada Semi-solid Dosage Market Size, 2018-2029
6.4.5 Mexico Semi-solid Dosage Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Semi-solid Dosage Revenue, 2018-2029
6.5.2 By Country – Europe Semi-solid Dosage Sales, 2018-2029
6.5.3 Germany Semi-solid Dosage Market Size, 2018-2029
6.5.4 France Semi-solid Dosage Market Size, 2018-2029
6.5.5 U.K. Semi-solid Dosage Market Size, 2018-2029
6.5.6 Italy Semi-solid Dosage Market Size, 2018-2029
6.5.7 Russia Semi-solid Dosage Market Size, 2018-2029
6.5.8 Nordic Countries Semi-solid Dosage Market Size, 2018-2029
6.5.9 Benelux Semi-solid Dosage Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Semi-solid Dosage Revenue, 2018-2029
6.6.2 By Region – Asia Semi-solid Dosage Sales, 2018-2029
6.6.3 China Semi-solid Dosage Market Size, 2018-2029
6.6.4 Japan Semi-solid Dosage Market Size, 2018-2029
6.6.5 South Korea Semi-solid Dosage Market Size, 2018-2029
6.6.6 Southeast Asia Semi-solid Dosage Market Size, 2018-2029
6.6.7 India Semi-solid Dosage Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Semi-solid Dosage Revenue, 2018-2029
6.7.2 By Country – South America Semi-solid Dosage Sales, 2018-2029
6.7.3 Brazil Semi-solid Dosage Market Size, 2018-2029
6.7.4 Argentina Semi-solid Dosage Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Semi-solid Dosage Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Semi-solid Dosage Sales, 2018-2029
6.8.3 Turkey Semi-solid Dosage Market Size, 2018-2029
6.8.4 Israel Semi-solid Dosage Market Size, 2018-2029
6.8.5 Saudi Arabia Semi-solid Dosage Market Size, 2018-2029
6.8.6 UAE Semi-solid Dosage Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Semi-solid Dosage Major Product Offerings
7.1.4 Johnson & Johnson Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Merck & Co
7.2.1 Merck & Co Company Summary
7.2.2 Merck & Co Business Overview
7.2.3 Merck & Co Semi-solid Dosage Major Product Offerings
7.2.4 Merck & Co Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.2.5 Merck & Co Key News & Latest Developments
7.3 Bayer AG
7.3.1 Bayer AG Company Summary
7.3.2 Bayer AG Business Overview
7.3.3 Bayer AG Semi-solid Dosage Major Product Offerings
7.3.4 Bayer AG Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.3.5 Bayer AG Key News & Latest Developments
7.4 Hisamitsu Pharmaceutical
7.4.1 Hisamitsu Pharmaceutical Company Summary
7.4.2 Hisamitsu Pharmaceutical Business Overview
7.4.3 Hisamitsu Pharmaceutical Semi-solid Dosage Major Product Offerings
7.4.4 Hisamitsu Pharmaceutical Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.4.5 Hisamitsu Pharmaceutical Key News & Latest Developments
7.5 Glenmark Pharmaceuticals
7.5.1 Glenmark Pharmaceuticals Company Summary
7.5.2 Glenmark Pharmaceuticals Business Overview
7.5.3 Glenmark Pharmaceuticals Semi-solid Dosage Major Product Offerings
7.5.4 Glenmark Pharmaceuticals Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.5.5 Glenmark Pharmaceuticals Key News & Latest Developments
7.6 Cipla Ltd
7.6.1 Cipla Ltd Company Summary
7.6.2 Cipla Ltd Business Overview
7.6.3 Cipla Ltd Semi-solid Dosage Major Product Offerings
7.6.4 Cipla Ltd Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.6.5 Cipla Ltd Key News & Latest Developments
7.7 Nestle SA
7.7.1 Nestle SA Company Summary
7.7.2 Nestle SA Business Overview
7.7.3 Nestle SA Semi-solid Dosage Major Product Offerings
7.7.4 Nestle SA Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.7.5 Nestle SA Key News & Latest Developments
7.8 Novartis AG
7.8.1 Novartis AG Company Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Semi-solid Dosage Major Product Offerings
7.8.4 Novartis AG Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.8.5 Novartis AG Key News & Latest Developments
7.9 GlaxoSmithKline plc
7.9.1 GlaxoSmithKline plc Company Summary
7.9.2 GlaxoSmithKline plc Business Overview
7.9.3 GlaxoSmithKline plc Semi-solid Dosage Major Product Offerings
7.9.4 GlaxoSmithKline plc Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.9.5 GlaxoSmithKline plc Key News & Latest Developments
7.10 Bausch Health Companies
7.10.1 Bausch Health Companies Company Summary
7.10.2 Bausch Health Companies Business Overview
7.10.3 Bausch Health Companies Semi-solid Dosage Major Product Offerings
7.10.4 Bausch Health Companies Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.10.5 Bausch Health Companies Key News & Latest Developments
7.11 Allergan
7.11.1 Allergan Company Summary
7.11.2 Allergan Semi-solid Dosage Business Overview
7.11.3 Allergan Semi-solid Dosage Major Product Offerings
7.11.4 Allergan Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.11.5 Allergan Key News & Latest Developments
7.12 Biofrontera
7.12.1 Biofrontera Company Summary
7.12.2 Biofrontera Semi-solid Dosage Business Overview
7.12.3 Biofrontera Semi-solid Dosage Major Product Offerings
7.12.4 Biofrontera Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.12.5 Biofrontera Key News & Latest Developments
7.13 Crown Laboratories
7.13.1 Crown Laboratories Company Summary
7.13.2 Crown Laboratories Semi-solid Dosage Business Overview
7.13.3 Crown Laboratories Semi-solid Dosage Major Product Offerings
7.13.4 Crown Laboratories Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.13.5 Crown Laboratories Key News & Latest Developments
7.14 Akorn
7.14.1 Akorn Company Summary
7.14.2 Akorn Business Overview
7.14.3 Akorn Semi-solid Dosage Major Product Offerings
7.14.4 Akorn Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.14.5 Akorn Key News & Latest Developments
7.15 Ingenus Pharmaceuticals
7.15.1 Ingenus Pharmaceuticals Company Summary
7.15.2 Ingenus Pharmaceuticals Business Overview
7.15.3 Ingenus Pharmaceuticals Semi-solid Dosage Major Product Offerings
7.15.4 Ingenus Pharmaceuticals Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.15.5 Ingenus Pharmaceuticals Key News & Latest Developments
7.16 Sun Pharmaceuticals
7.16.1 Sun Pharmaceuticals Company Summary
7.16.2 Sun Pharmaceuticals Business Overview
7.16.3 Sun Pharmaceuticals Semi-solid Dosage Major Product Offerings
7.16.4 Sun Pharmaceuticals Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.16.5 Sun Pharmaceuticals Key News & Latest Developments
7.17 Crescita Therapeutics
7.17.1 Crescita Therapeutics Company Summary
7.17.2 Crescita Therapeutics Business Overview
7.17.3 Crescita Therapeutics Semi-solid Dosage Major Product Offerings
7.17.4 Crescita Therapeutics Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.17.5 Crescita Therapeutics Key News & Latest Developments
7.18 Mylan N.V.
7.18.1 Mylan N.V. Company Summary
7.18.2 Mylan N.V. Business Overview
7.18.3 Mylan N.V. Semi-solid Dosage Major Product Offerings
7.18.4 Mylan N.V. Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.18.5 Mylan N.V. Key News & Latest Developments
7.19 Encore Dermatology
7.19.1 Encore Dermatology Company Summary
7.19.2 Encore Dermatology Business Overview
7.19.3 Encore Dermatology Semi-solid Dosage Major Product Offerings
7.19.4 Encore Dermatology Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.19.5 Encore Dermatology Key News & Latest Developments
7.20 LEO Pharma
7.20.1 LEO Pharma Company Summary
7.20.2 LEO Pharma Business Overview
7.20.3 LEO Pharma Semi-solid Dosage Major Product Offerings
7.20.4 LEO Pharma Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.20.5 LEO Pharma Key News & Latest Developments
7.21 Almirall, S.A
7.21.1 Almirall, S.A Company Summary
7.21.2 Almirall, S.A Business Overview
7.21.3 Almirall, S.A Semi-solid Dosage Major Product Offerings
7.21.4 Almirall, S.A Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.21.5 Almirall, S.A Key News & Latest Developments
7.22 Aclaris Therapeutics
7.22.1 Aclaris Therapeutics Company Summary
7.22.2 Aclaris Therapeutics Business Overview
7.22.3 Aclaris Therapeutics Semi-solid Dosage Major Product Offerings
7.22.4 Aclaris Therapeutics Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.22.5 Aclaris Therapeutics Key News & Latest Developments
7.23 Taro Pharmaceutical Industries
7.23.1 Taro Pharmaceutical Industries Company Summary
7.23.2 Taro Pharmaceutical Industries Business Overview
7.23.3 Taro Pharmaceutical Industries Semi-solid Dosage Major Product Offerings
7.23.4 Taro Pharmaceutical Industries Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.23.5 Taro Pharmaceutical Industries Key News & Latest Developments
7.24 Teligent Pharma
7.24.1 Teligent Pharma Company Summary
7.24.2 Teligent Pharma Business Overview
7.24.3 Teligent Pharma Semi-solid Dosage Major Product Offerings
7.24.4 Teligent Pharma Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.24.5 Teligent Pharma Key News & Latest Developments
7.25 Perrigo Pharma
7.25.1 Perrigo Pharma Company Summary
7.25.2 Perrigo Pharma Business Overview
7.25.3 Perrigo Pharma Semi-solid Dosage Major Product Offerings
7.25.4 Perrigo Pharma Semi-solid Dosage Sales and Revenue in Global (2018-2023)
7.25.5 Perrigo Pharma Key News & Latest Developments
8 Global Semi-solid Dosage Production Capacity, Analysis
8.1 Global Semi-solid Dosage Production Capacity, 2018-2029
8.2 Semi-solid Dosage Production Capacity of Key Manufacturers in Global Market
8.3 Global Semi-solid Dosage Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Semi-solid Dosage Supply Chain Analysis
10.1 Semi-solid Dosage Industry Value Chain
10.2 Semi-solid Dosage Upstream Market
10.3 Semi-solid Dosage Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Semi-solid Dosage Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 半固体投与量の世界市場見通し2023年-2029年(Semi-solid Dosage Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 半自動充填装置のグローバル市場展望 2023年-2029年：固体、半固体、液体
  • ソリッドブースターの世界市場見通し2023年-2029年
  • 固体レーザーの世界市場見通し2023年-2029年
  • 固体水素貯蔵ソリューションの世界市場見通し2023年-2029年
  • 世界の経口固形剤形（OSDF）＆医薬品添加剤市場2022年：グリセリン、プロピレングリコール、ソルビトール、マンニトール、その他